Action GLAND GLAND PHARMA LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Gland Pharma Limited

Actions

GLAND

INE068V01023

Temps Différé NSE India S.E.
Autres places de cotation
 05:50:59 27/06/2024 		Varia. 5j. Varia. 1 janv.
1 807 INR +1,25 % Graphique intraday de Gland Pharma Limited -1,52 % -6,31 %
20/06 Fosun Pharma réduit sa participation dans Gland Pharma à 51,83%. MT
18/06 Fosun Pharma Industrial réduirait sa participation de 5% dans Gland Pharma pour 172 millions de dollars CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Fosun Pharma Trims Stake in Gland Pharma to 51.83%
Fosun Pharma Industrial Reportedly to Pare 5% Stake in Gland Pharma for $172 Million
Gland Pharma Limited Announces Management Changes
Gland Pharma Limited Announces Resignation of C.S. Venkatesan as Sr. Vice President (R&D) and SMP, Effective June 30, 2024 and July 1, 2024 Respectively
Gland Pharma Gets Zero Observations from US FDA for API Facility in Andhra Pradesh, India
Gland Pharma Posts Surge in Fiscal Q4 Consolidated Net Profit
Gland Pharma Limited Board Recommends Final Dividend for the Fiscal Year Ending March 31, 2024
Gland Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Gland Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Gland Pharma Gets US FDA's Approval for Generic ALS Drug
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Edaravone Injection
Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Plerixafor Injection
KKR to buy India's Healthium Medtech at $839 million valuation, sources say
Gland Pharma Names COO
Gland Pharma Limited Approves Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer, Effective May 1 ,2024
Gland Pharma Gets US FDA's Final Approval for Generic Drug for Luteinizing Hormone Surges
Gland Pharma Receives Approval for Cetrorelix Acetate for Injection
Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals
Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action GLAND
  4. Actualités Gland Pharma Limited
  5. Autres langues